Literature DB >> 17453828

Melanoma-associated antigen family protein-D1 regulation of tumor cell migration, adhesion to endothelium, and actin structures reorganization in response to hypoxic stress.

Wei-Gan Shen1, Qing-Yu Xue, Yi-Ding Wu, Ben-Shun Hu, Jun Zhu, Yu Zhang, Qing Su.   

Abstract

Melanoma-associated antigen family protein-D1 (MAGE-D1) is a recently identified p75 neurotrophin receptor intracellular binding protein and functions as an adaptor that mediates multiple signaling pathways, including Dlx/Msx-mediated transcription. Here, a new regulatory function for MAGE-D1 in tumor cell motility and adhesion to endothelium is described. MAGE-D1 over-expression suppressed HeLa cell and BEL7402 cell migration, invasion, and adhesion to the monolayer of ECV304 cells. We also report that MAGE-D1 over-expression disrupted actin cytoskeleton rearrangement induced by hypoxia and down-regulated hypoxia inducible factor 1-dependent luciferase gene expression. These findings provide new insight into the ability of MAGE-D1 to suppress the motility and adhesion response of tumor cells by interfering with actin cytoskeleton reorganization and hypoxia inducible factor 1-dependent gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453828     DOI: 10.1080/15419060701224948

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  3 in total

Review 1.  Complex roles of NRAGE on tumor.

Authors:  Ge Zhang; Huandi Zhou; Xiaoying Xue
Journal:  Tumour Biol       Date:  2016-05-21

Review 2.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

3.  FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma.

Authors:  Ana Belén Herrero; Dalia Quwaider; Luis Antonio Corchete; Maria Victoria Mateos; Ramón García-Sanz; Norma C Gutiérrez
Journal:  J Cell Mol Med       Date:  2020-03-06       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.